Biomedical researchers can see a future where genetic tests are used to treat and prevent many diseases before major symptoms even present themselves. But that future won't be possible without strong insurance protections for pre-existing conditions.
Before a 2012 contraceptive mandate, 30 to 44 percent of women's medical spending used to go toward birth control. After the mandate, those numbers fell to 13 to 22 percent.